AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

36.00
Data as of Nov 21
 +0.41 / +1.15%
Today’s Change
16.49
Today|||52-Week Range
36.40
+48.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$795.4M

Company Description

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. It focused on the development and commercialization of Feraheme injection for intravenous or IV, use to treat iron deficiency anemia or IDA. The company engages in manufacture, development and commercialization of products derived from its proprietary technology for use in treating human diseases. AMAG Pharmaceuticals was founded in November 1981 and is headquartered in Lexington, MA.

Contact Information

AMAG Pharmaceuticals, Inc.
100 Hayden Avenue
Lexington Massachusetts 02421
P:(617) 498-3300
Investor Relations:

Employees

Shareholders

Other institutional82.38%
Mutual fund holders38.91%
Individual stakeholders27.03%

Top Executives

William K. HeidenPresident, Chief Executive Officer & Director
Frank E. ThomasChief Operating Officer & Executive Vice President
Scott A. HolmesTreasurer, CAO, SVP-Finance & Investor Relations
Scott T. McMillanSenior VP-Quality & Technical Operations
Robert KaperSenior Vice President-Medical & Scientific Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.